Kiran Mazumdar-Shaw names niece Claire Mazumdar as successor at Biocon. Explore the leadership transition, strategy, and future plans.
'Leadership is about understanding how a business works, how it is shaped, built, and expanded.'
Biocon chief Kiran Mazumdar-Shaw met with Karnataka's Chief Minister and Deputy Chief Minister on Diwali, amidst ongoing concerns about Bengaluru's infrastructure.
'I have added to the covid count by testing positive. Mild symptoms and I hope it stays that way,' the 67-year-old biotechnology industry veteran said in a tweet.
The story of Kiran Mazumdar-Shaw is one of grit, self confidence and courage. If today she is one of the most successful entrepreneurs in the world, it is because of her determination.
Beyond her avatar as the head of a multi-crore biotech company, Kiran Mazumdar-Shaw is a powerful voice of change for the city she lives in.
Biocon chairperson and managing director Kiran Mazumdar-Shaw is in a firefighting mode, as the company she founded was forced to call off a blockbuster deal with global pharmaceutical major Pfizer.
Biocon CMD Kiran Mazumdar-Shaw has been named in the world's top 100 'effective and talented' people by US-based 'Scientific American' magazine.
While mostly corporates, including established names and little-known ones, went for the top-denomination bonds, there were also several individuals who bought multiple such bonds.
The entrepreneur reveals interesting nuggets about her life and career.
"Karnataka has always forged inclusive economic development and we must not allow such communal exclusion- If ITBT became communal it would destroy our global leadership. @BSBommai please resolve this growing religious divide," Mazumdar-Shaw said.
Kiran Mazumdar-Shaw talks to Nikita Puri about her book Mythbreaker.
"Tendulkar's attorney said the cricket player's investment is legitimate and has been declared to tax authorities. Shakira's attorney said the singer declared her companies, which the attorney said do not provide tax advantages. Schiffer's representatives said the supermodel correctly pays her taxes in the UK, where she lives," it notes.
A day after she praised Rohan Murthy's performance at Infosys' board meeting, the firm's newly-appointed independent director and Biocon head Kiran Mazumdar Shaw on Wednesday apologised for the remarks.
Testing only those with symptoms is not such a great idea. A lot of asymptomatic people are also positive. Its also important to do some amount of random testing in the clusters. You need to do lot more testing. The more you test, the more positives you get. Only redeeming feature is that the number of those getting into ICU or dying is not huge, she said.
Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.
Taking a break from their hectic schedule and boardroom meetings, nine CEOs would display their singing prowess at a charity dinner event in Bengaluru to raise funds for children on July 16.
After registering encouraging data from oral insulin trials, Biocon is looking to partner on this with global pharma firms.
At the meeting of the Board of Governors of IIM Bengaluru held on February 11, the chairperson, Mukesh D Ambani, expressed his decision to step down, IIM-B said.
Karnataka Deputy Chief Minister D K Shivakumar responds to criticism regarding Bengaluru's infrastructure, while industry leaders and opposition members voice their concerns.
Biocon Ltd on Tuesday said it has earned the distinction of being the only Asian biopharma company to feature among the top biotechnology employers in the world as ranked by Science magazine.
The company has launched the product in 10ml and 3ml vials, Biocon said.
The Bengaluru-based firm has entered into a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialisation of generic versions of its three insulin analog products, Biocon Ltd said in a statement.
India's largest biotech firm Biocon on Wednesday launched its "recombinant human insulin (r-DNA), Insugen
The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon Biologics under development to manage Type 1 and Type 2 diabetes, officials said on Tuesday. Biocon Biologics is a subsidiary of the Kiran Mazumdar Shaw-led Biocon. The company has denied allegations. The agency has also arrested Dinesh Dua, director at Synergy Network India Private Limited, who was allegedly giving Reddy a bribe, they said.
Mazumdar-Shaw left open whether Biocon will go in for a higher stake or will completely take over the company, which is located near Frankfurt and specialises in manufacturing and marketing a unique range of its own patent-free medicines as well as low-cost drugs from Europan Union nations.
Every year, BioSingapore receives nominations from biotechnology industry associations, industry peers, academics and institutions across Asia-Pacific for the most outstanding companies or individuals in various categories. The nominees are judged by a panel of distinguished leaders in the field.
On course to become India's first biotech company to be listed on a stock exchange, Bangalore-based Biocon Ltd on Thursday kicked off a roadshow for its initial public offering that opens on March 11.
Leading biotech firm, Biocon Ltd, on Tuesday said it would invest $10 million (about Rs 45 crore) in the next 12 months to expand its facilities.
Nobex, after running out of money last year, had filed for bankruptcy.
Biotech major Biocon will file an application with the US Federal Drug Administration to begin clinical trials for oral insulin, which, it says, would be the world's first insulin that could be consumed orally.
Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR.
Biocon, India's top biotech company, is looking to go in for listing of its stocks overseas in two years time, said its chairman and managing director Kiran Mazumdar-Shaw.
New Zealand Prime Minister Helen Clarke on Monday said there were immense opportunities to enhance bilateral trade with India.
Biotechnology major Biocon India Ltd plans to invest over Rs 500 crore on its expansion plans over the next two years.
Proxy advisory firms say the praise on Twitter was uncalled for.
Biotechnology major Biocon has got the Drug and Controller General of India approval for marketing its BIOMAb EGFR in the Indian market. This is a proprietary product of Biocon, which will be used in treating head and neck cancers.
